№ files_lp_4_process_3_115529
Regulatory and institutional guideline outlining procedures, responsibilities, and reporting requirements for adverse events and other safety-related occurrences during human subjects clinical research.
Document Type: Standard Practice Guideline
Subject Area: Clinical research safety and adverse event reporting
Regulatory Framework: Good Clinical Practice (ICH GCP)
Regulatory References: ICH GCP Sections 4.11.1, 4.11.2, 5.16, 5.17; 21 CFR 312.53, 312.64, 312.66, 312.32; 21 CFR 812.150
Institution: University of Michigan Institutional Review Board (IRBMED)
Applicable To: Clinical trial staff including Principal Investigator, Sponsor-Investigator, Co-Investigator, Study Coordinators, and research personnel
Key Topics: Adverse Events (AE), Serious Adverse Events (SAE), Unanticipated Adverse Device Effects (UADE), Unanticipated Problems (UaP)
Responsible Roles: Principal Investigator, Sponsor-Investigator, Co-Investigators, Study Coordinators, Data and Safety Monitoring Board
Research Context: Human subjects clinical trials
Reporting Authorities: Sponsor, Institutional Review Board (IRB), Food and Drug Administration (FDA)
Geographical Context: United States regulatory environment
Compliance Basis: Federal regulations and institutional research oversight policies
Purpose: Procedures and responsibilities for identification, assessment, documentation, and reporting of safety events in clinical studies
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.